Key Points
- Director Philip Hawkins sold 5,536 shares at an average price of $32.71 (transaction ~$181,082.56), cutting his holding by 26.71% to 15,188 shares valued at $496,799.48 per the SEC filing.
- COPT raised its quarterly dividend to $0.32 (annualized $1.28) for a 4.0% yield, with an ex-dividend date of March 31 and payment on April 15; the dividend payout ratio is 90.37%.
- The company reported quarterly EPS of $0.70 (vs. $0.68 expected) and revenue of $197.36M (vs. $188.79M expected), with revenue up 7.6% YoY and FY2026 guidance set at $2.710–$2.790 per share (analysts average ~2.67).
COPT Defense Properties (NYSE:CDP - Get Free Report) Director Philip Hawkins sold 5,536 shares of the stock in a transaction on Monday, February 23rd. The stock was sold at an average price of $32.71, for a total transaction of $181,082.56. Following the sale, the director directly owned 15,188 shares of the company's stock, valued at $496,799.48. This represents a 26.71% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
COPT Defense Properties Stock Down 1.2%
Shares of COPT Defense Properties stock opened at $32.25 on Wednesday. The firm has a market cap of $3.65 billion, a PE ratio of 23.89 and a beta of 0.86. The business's 50 day simple moving average is $30.13 and its 200 day simple moving average is $29.45. The company has a debt-to-equity ratio of 1.77, a quick ratio of 2.34 and a current ratio of 3.95. COPT Defense Properties has a 52-week low of $23.92 and a 52-week high of $32.82.
COPT Defense Properties (NYSE:CDP - Get Free Report) last released its quarterly earnings results on Thursday, February 5th. The company reported $0.70 earnings per share for the quarter, topping analysts' consensus estimates of $0.68 by $0.02. COPT Defense Properties had a return on equity of 9.82% and a net margin of 19.94%.The firm had revenue of $197.36 million during the quarter, compared to the consensus estimate of $188.79 million. During the same quarter in the prior year, the firm posted $0.65 EPS. The business's revenue was up 7.6% on a year-over-year basis. COPT Defense Properties has set its FY 2026 guidance at 2.710-2.790 EPS and its Q1 2026 guidance at 0.670-0.690 EPS. On average, analysts predict that COPT Defense Properties will post 2.67 earnings per share for the current fiscal year.
COPT Defense Properties Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Tuesday, March 31st will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 4.0%. The ex-dividend date is Tuesday, March 31st. This is an increase from COPT Defense Properties's previous quarterly dividend of $0.31. COPT Defense Properties's dividend payout ratio (DPR) is presently 90.37%.
Institutional Trading of COPT Defense Properties
Hedge funds have recently modified their holdings of the stock. California State Teachers Retirement System boosted its stake in COPT Defense Properties by 0.4% in the 2nd quarter. California State Teachers Retirement System now owns 104,190 shares of the company's stock valued at $2,874,000 after purchasing an additional 457 shares during the period. Arizona State Retirement System increased its position in COPT Defense Properties by 1.4% during the third quarter. Arizona State Retirement System now owns 33,402 shares of the company's stock worth $971,000 after acquiring an additional 459 shares during the period. GAMMA Investing LLC raised its stake in COPT Defense Properties by 31.2% in the 3rd quarter. GAMMA Investing LLC now owns 1,973 shares of the company's stock worth $57,000 after purchasing an additional 469 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in COPT Defense Properties by 2.5% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 20,780 shares of the company's stock valued at $588,000 after purchasing an additional 513 shares during the period. Finally, Arkadios Wealth Advisors grew its position in shares of COPT Defense Properties by 4.5% during the 3rd quarter. Arkadios Wealth Advisors now owns 12,672 shares of the company's stock worth $368,000 after purchasing an additional 540 shares in the last quarter.
Wall Street Analyst Weigh In
CDP has been the subject of several analyst reports. Weiss Ratings restated a "buy (b-)" rating on shares of COPT Defense Properties in a report on Wednesday, January 21st. Citigroup increased their price target on COPT Defense Properties from $29.00 to $34.00 and gave the company a "neutral" rating in a research report on Tuesday, February 10th. Jefferies Financial Group boosted their price target on COPT Defense Properties from $33.00 to $34.00 and gave the stock a "buy" rating in a research report on Tuesday, January 27th. Cantor Fitzgerald increased their price objective on COPT Defense Properties from $33.00 to $37.00 and gave the company an "overweight" rating in a report on Monday, February 9th. Finally, Truist Financial raised their target price on shares of COPT Defense Properties from $30.00 to $31.00 and gave the company a "hold" rating in a research note on Monday, December 15th. Five research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, COPT Defense Properties has a consensus rating of "Moderate Buy" and a consensus price target of $33.63.
Check Out Our Latest Analysis on CDP
COPT Defense Properties Company Profile
(
Get Free Report)
COPT Defense Properties (NYSE: CDP) is a real estate investment trust organized to own, lease and manage healthcare and life science facilities serving the United States federal government, with a particular focus on Department of Defense and Veterans Affairs tenants. The company was formed in 2016 through a spin-off from Corporate Office Properties Trust, enabling it to concentrate exclusively on medical office buildings and specialized research facilities situated on or near military and federal research campuses.
The company's portfolio comprises purpose-built, Class A medical office and outpatient specialty clinics, as well as life science laboratories.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
